Stockscreener 앱 받기
6.67
8.25%
-0.60
전일 마감가:
$7.27
열려 있는:
$6.85
하루 거래량:
1.51M
Relative Volume:
2.81
시가총액:
$206.78M
수익:
-
순이익/손실:
$-29.25M
주가수익비율:
-5.6239
EPS:
-1.186
순현금흐름:
$-22.80M
1주 성능:
-13.94%
1개월 성능:
-14.27%
6개월 성능:
+107.14%
1년 성능:
+48.22%
1일 변동 폭
$6.32
$7.01
1주일 범위
$6.32
$8.15
52주 변동 폭
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
명칭
Sagimet Biosciences Inc
전화
(650) 561-8600
주소
155 BOVET RD., SUITE 303, SAN MATEO
SGMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
6.67 | 236.43M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 개시 | Wedbush | Outperform |
| 2025-08-07 | 재개 | H.C. Wainwright | Buy |
| 2025-07-24 | 개시 | Canaccord Genuity | Buy |
| 2024-12-06 | 개시 | Oppenheimer | Outperform |
| 2024-11-12 | 개시 | UBS | Buy |
| 2024-06-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-05-02 | 개시 | H.C. Wainwright | Buy |
| 2024-03-25 | 개시 | Leerink Partners | Outperform |
| 2023-08-08 | 개시 | Goldman | Buy |
| 2023-08-08 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-08 | 개시 | Piper Sandler | Overweight |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
모두보기
Sagimet Biosciences Inc 주식(SGMT)의 최신 뉴스
Sagimet Biosciences executive chairman sells $290k in shares By Investing.com - Investing.com Australia
Sagimet Biosciences executive chairman sells $290k in shares - Investing.com
Will Sagimet Biosciences Inc. (0O2) stock sustain bullish trend into 2025Weekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Sagimet Biosciences Inc. to Participate in 8th Annual Evercore ISI Healthcare Conference on December 2, 2025 - Quiver Quantitative
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewswire
Why Sagimet Biosciences Inc. (0O2) stock attracts wealthy investorsMarket Risk Summary & Growth Focused Investment Plans - newser.com
Can Sagimet Biosciences Inc. (0O2) stock attract analyst upgradesPortfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
What catalysts could drive Sagimet Biosciences Inc. stock higherPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
Is Sagimet Biosciences Inc. (0O2) stock worth holding before Fed meetingWeekly Trade Recap & Fast Entry Momentum Trade Alerts - newser.com
Detecting support and resistance levels for Sagimet Biosciences Inc.July 2025 Outlook & Safe Capital Preservation Plans - newser.com
Sagimet Biosciences Inc (0O2.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Sagimet Biosciences Inc. (0O2) stock a buy during volatile marketsJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
How sustainable is Sagimet Biosciences Inc. stock dividend payoutJuly 2025 Short Interest & Safe Capital Allocation Plans - newser.com
Identifying reversal signals in Sagimet Biosciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com
Reversal indicators forming on Sagimet Biosciences Inc. stockWeekly Stock Summary & Consistent Income Trade Recommendations - newser.com
How cyclical is Sagimet Biosciences Inc. (0O2) stock compared to rivalsJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Published on: 2025-11-19 02:00:25 - newser.com
Will Sagimet Biosciences Inc. rebound enough to break evenGap Down & Comprehensive Market Scan Reports - newser.com
How Sagimet Biosciences Inc. (0O2) stock trades after earningsAnalyst Downgrade & Real-Time Buy Signal Alerts - newser.com
Sagimet Biosciences Advances Denifanstat: Q3 Earnings And Upcoming Catalysts - Seeking Alpha
Is Sagimet Biosciences Inc. stock resilient to inflation2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
Sagimet Biosciences, Inc.: Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
How Sagimet Biosciences Inc. stock compares to market leadersOptions Play & Daily Growth Stock Tips - newser.com
Key metrics from Sagimet Biosciences Inc.’s quarterly dataInsider Buying & Weekly Stock Performance Updates - newser.com
What does recent volatility data suggest for Sagimet Biosciences Inc.2025 Biggest Moves & Precise Buy Zone Identification - newser.com
Sagimet Biosciences Inc (SGMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):